Russell Investments Group, Ltd.

Position in JBIO — Jade Biosciences, Inc.

CIK 1692234 Seattle, WA

Position in JBIO

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$3,623,724

+$2,112,002 QoQ

Shares Held

163,084

+51.6% QoQ

Ownership

0.256%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 153 holders

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 93% Shared 0% None 7%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. JBIO ranks #63 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,623,724	163,084	+51.6%	Shares	Defined	2026-08-06
2026-03-31	$1,511,722	107,596	+1713.8%	Shares	Defined	2026-05-08
2025-12-31	$91,530	5,932	+34.1%	Shares	Defined	2026-02-17
2025-09-30	$38,161	4,422	+40.7%	Shares	Defined	2025-11-13
2025-06-30	$31,398	3,143	—	Shares	Defined	2025-08-13
2025-03-31 AVTE	—	32,395	+113.3%	Shares	Defined	2025-05-13
2024-12-31 AVTE	—	15,184	+110.7%	Shares	Defined	2025-02-13
2024-09-30 AVTE	—	7,207	+102857.1%	Shares	Defined	2024-11-13
2024-03-31 AVTE	—	7	-99.3%	Shares	Defined	2024-05-08
2023-06-30 AVTE	—	939	0.0%	Shares	Defined	2023-08-10
2023-03-31 AVTE	—	939	-20.1%	Shares	Defined	2023-05-09
2022-12-31 AVTE	—	1,175	0.0%	Shares	Defined	2023-02-08
2022-09-30 AVTE	—	1,175	-42.9%	Shares	Defined	2022-11-04
2022-06-30 AVTE	—	2,056	—	Shares	Defined	2022-07-29
No filing history on record for this holder in this stock.